Navigation Links
Global cardiology leaders meet in Dubai
Date:4/13/2012

Sophia Antipolis, 13 April 2012: European Society of Cardiology (ESC) leaders will be present at the World Congress of Cardiology (WCC) in Dubai to help raise awareness of the global burden of cardiovascular disease. CVD remains the main cause of death in the world even though most cardiac events could be prevented. As a member of the NCD Alliance , the ESC is pushing for a number of targets such as 80% coverage of multidrug therapy for people at risk of heart attack or stroke; targets on all major risk factors including exercise, smoking, salt, blood pressure, alcohol, and obesity; and a target to reduce preventable deaths from non-communicable diseases by 25% by 2025. The World Congress of Cardiology is organised by the World Heart Federation (WHF) .

World Health Organization (WHO) targets for non-communicable diseases -including cardiovascular disease- are set to be a hot topic for debate. The ESC has been working with European Union policy makers and national policy makers, with the help of national cardiac societies, to raise awareness of the targets and push governments for action.

Leaders from the ESC, American College of Cardiology, American Heart Association and World Heart Federation (WHF) will meet to discuss the targets and other pressing global issues in cardiovascular disease.

Professor Panos Vardas (Greece), President Elect of the ESC, says the meeting "will be a step further in the global fight against cardiovascular disease". He adds: "I am going to the WCC in Dubai because this important scientific meeting, with participants coming from all over the world, will provide the ESC with a fresh opportunity to contact delegates from Asian, Latin American and African countries where we are hoping to expand our activities. As CVD increases world-wide, so does demand for the ESC's scientific knowledge."

A large leadership delegation from the ESC will attend the Congress, including Professor Michel Komajda (France), ESC President and Chairman of the ESC Global Scientific Activities Committee.

ESC members are participating as topic group leaders and experts. Basic Science for example will see contributions from European Heart Journal editor Professor Thomas Lscher (Switzerland) as a topic group leader and ESC Past President Roberto Ferrari (Italy) as a topic group expert.

Professor Ferrari, who is also a board member of the WHF, says: "The WCC offers a very broad view of cardiology not only in developed countries, but also in the less developed countries. Sometimes this information is important and relevant for our profession." He adds: "Nowadays in Italy for instance we have much more immigration than in the past and it is not rare to be confronted with conditions like Chagas disease. In this congress we learn about these types of diseases."

Professor Jeroen Bax (Netherlands) is a co-chair of the Scientific Programme Committee for this year's Congress, which will feature joint ESC sessions. One session will be devoted to innovations for targeting the global challenge of cardiovascular disease, such as bromocriptine for peripartal cardiomyopathy and renal denervation for resistant hypertension. Another session will focus on implementing the ESC and European Association for Cardio-Thoracic Surgery guidelines on myocardial revascularisation.

The ESC last organised the WCC in 2006, when it was held in Barcelona as a joint event with the ESC Congress. It set a record for WCC attendance, attracting more than 32,500 participants from over 100 countries. The next major international event in cardiology is the ESC Congress 2012 which takes place from 25 to 29 August in Munich, Germany.


'/>"/>
Contact: ESC Press Office
press@escardio.org
33-049-294-8627
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. Canada should play a role in addressing the global cancer epidemic
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Malarias Global Death Toll Much Higher Than Thought
4. Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC
5. Global Study Finds Drug Abuse Highest in Richer Nations
6. IBD emerges as a global disease
7. Are Global Market Forces Linked to Obesity Epidemic?
8. Transending Borders Towards Global Health
9. Emory and US CDC partner to continue building global public health network with $6 million grant
10. Global conference on stem cell therapy to be held Jan. 25-27, 2012 in New York City
11. Global Carbon Project annual emissions summary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... , ... April 26, 2017 ... ... provides an agile ecosystem and domain expertise for sponsors and CROs to ... and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... San Jose, CA (PRWEB) , ... April 25, ... ... in cross-screen access, support, and collaboration, announces Mirroring360 Pro . This new ... providing a comprehensive collaboration experience for education and business. , Mirroring360 Pro enables ...
(Date:4/25/2017)... ... ... A stressful work environment can hurt the physical and emotional health of employees. ... workplace. The goal of Clearview Resolution Services has always been to help others, starting ... will be shutting down the office early on Fridays. The Clearview team will use ...
(Date:4/25/2017)... ... 25, 2017 , ... The doctors at Wall Centre Dental are now expanding ... and require sedation to receive dental care. The doctors offer three treatment options to ... cleanings to oral surgery, at their dental office in Vancouver. Wall Centre Dental is ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
Breaking Medicine Technology: